Emanuelle Mamroud Selected Research

Proteins (Proteins, Gene)

3/2021	Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection.
1/2018	Improved production of monoclonal antibodies against the LcrV antigen of Yersinia pestis using FACS-aided hybridoma selection.
5/2015	Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
7/2010	The search for early markers of plague: evidence for accumulation of soluble Yersinia pestis LcrV in bubonic and pneumonic mouse models of disease.
1/2003	Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.
1/2003	Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuelle Mamroud Research Topics

Disease

27	Plague (Bubonic Plague) 10/2023 - 01/2003
16	Infections 06/2023 - 01/2003
3	Bacterial Infections (Bacterial Infection) 06/2023 - 01/2012
3	COVID-19 01/2022 - 12/2020
3	Disease Progression 10/2020 - 01/2013
1	Starvation 06/2023
1	Human Influenza (Influenza) 11/2020
1	Virus Diseases (Viral Diseases) 11/2020
1	Anthrax 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Tularemia 01/2018

Drug/Important Bio-Agent (IBA)

11	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 01/2007
10	VaccinesIBA 10/2023 - 01/2003
8	AntigensIBA 10/2023 - 01/2003
6	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2003
3	IronIBA 06/2023 - 01/2017
3	Virulence Factors (Pathogenicity Factors)IBA 03/2021 - 09/2009
3	AntibodiesIBA 03/2021 - 03/2008
2	Messenger RNA (mRNA)IBA 10/2023 - 05/2015
2	Capsules (Microcapsules)IBA 10/2023 - 03/2023
2	Laminin (Merosin)IBA 01/2022 - 11/2020
2	CollagenIBA 01/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2018
2	Doxycycline (Periostat)FDA LinkGeneric 01/2021 - 11/2020
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2021 - 11/2020
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 09/2009
2	SuspensionsIBA 01/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2003 - 01/2003
1	NucleosidesIBA 10/2023
1	Proteoglycans (Proteoglycan)IBA 01/2022
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Bacterial RNAIBA 10/2021
1	CalciumIBA 03/2021
1	Monoclonal AntibodiesIBA 03/2021
1	EpitopesIBA 03/2021
1	AgarIBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 11/2020
1	Indicators and Reagents (Reagents)IBA 10/2020
1	Twin-Arginine-Translocation SystemIBA 01/2019
1	EnzymesIBA 01/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2018
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2018
1	AminoglycosidesIBA 01/2018
1	ProteomeIBA 10/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2015
1	Chemotactic FactorsIBA 05/2015
1	ChemokinesIBA 01/2012
1	CytokinesIBA 01/2012
1	Subunit VaccinesIBA 03/2008
1	Neutralizing AntibodiesIBA 03/2008
1	Attenuated VaccinesIBA 02/2004
1	DNA VaccinesIBA 01/2003
1	Bacterial Proteins (Bacterial Protein)IBA 01/2003

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2011
2	Phage Therapy 01/2022 - 01/2021